Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • aplany
    Junior Member
    • Aug 2011
    • 4

    #1

    Sequencing depth taken into account with FPKM?

    I had a question regarding FPKM calculations.

    I've sequenced transcriptomes for two different species and am comparing their response to a specific treatment. Both species have very similar genome sizes. However, I sequenced about 40 million 100bp-PE reads for one of the species and ~33 million for the other.

    I've done the mapping against their respective genomes using bowtie. However, I'm now concerned about coverage differences.

    When I am doing transcript quantification using RSEM, do I need to first randomly subsample the reads of the first species so I have the same depth of coverage going into quantititation, or will FPKM calculations take the coverage into account?
  • HESmith
    Senior Member
    • Oct 2009
    • 512

    #2
    Do you know what FPKM stands for? There's your answer.

    Comment

    • rflrob
      Member
      • May 2010
      • 50

      #3
      Less acerbicly, FPKM is fragments per kilobase per million mapped reads. That million mapped reads in the denominator should do an okay job of dealing with the coverage differences. The idea is that, for a given organism, you can go from FPKM to copy number per cell, only making a handful of overly-broad, almost-believable assumptions.

      It's worth bearing in mind, though, that simply comparing FPKMs between two samples won't do a very good job of pulling out statistically significant differences. For that, you should look into a program like DESeq, Cuffdiff, or edgeR.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      53 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      40 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      46 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      46 views
      0 reactions
      Last Post SEQadmin2  
      Working...